Targeted attack on lung cancer in the brain shows promise
NCT ID NCT07491211
Summary
This study looks back at medical records to see how well a combination treatment works for people with a specific type of advanced lung cancer that has spread to the brain and is causing symptoms. The treatment combines a targeted drug (osimertinib) with precise, focused radiation to the brain tumors. Researchers are analyzing data from 300 patients to understand if this approach helps control the cancer longer and is safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China, 200032, China
-
Shanghai Jiao Tong University Affiliated Chest Hospital
Shanghai, China
-
Wuhan Tongji Hospital
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.